Association of cerebrospinal fluid (CSF) insulin with cognitive performance and CSF biomarkers of Alzheimer’s disease

Manuscript Number: 

17-0522R1

Author(s): 
Pauline Aalten, Geert Jan Biessels, Peter Paul De Deyn, Stefan L.C. Geijselaers, Annemieke C. Heijboer, Huiberdina L. Koek, Marcel G.M. Olde Rikkert, Janne M. Papma, Inez H.G.B. Ramakers, Fransje E. Reesink, Lieke L. Smits, Coen D.A. Stehouwer, Charlotte E. Teunissen, Frans R. Verhey, Wiesje M. van der Flier

Disclosures

Pauline Aalten

  • Nothing to Disclose

Geert Jan Biessels

  • Grants
    • Agency: 
      Boehringer Ingelheim
      Dates: 
      2009-current

Peter Paul De Deyn

  • Nothing to Disclose

Stefan L.C. Geijselaers

  • Nothing to Disclose

Annemieke C. Heijboer

  • Nothing to Disclose

Huiberdina L. Koek

  • Nothing to Disclose

Marcel G.M. Olde Rikkert

  • Nothing to Disclose

Janne M. Papma

  • Nothing to Disclose

Inez H.G.B. Ramakers

  • Nothing to Disclose

Fransje E. Reesink

  • Nothing to Disclose

Lieke L. Smits

  • Nothing to Disclose

Coen D.A. Stehouwer

  • Nothing to Disclose

Charlotte E. Teunissen

  • Consulting Fees:
    Roche: advisory board.
    Lecture Fees:
    Axon Neurosciences.

Wiesje M. van der Flier

  • Nothing to Disclose

Frans R. Verhey

  • Nothing to Disclose